Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Fazlollahpour Naghibi A"'
Autor:
Amir Hossein Behnoush, Amirmohammad Khalaji, Andarz Fazlollahpour‐Naghibi, Kimia Bagheri, Parmis Goshtasbi, Ghazal Mohseni, Aouatif Erasmia El Kanty, Caterina Vinciguerra, Alessandro Cannavo
Publikováno v:
ESC Heart Failure, Vol 11, Iss 5, Pp 3253-3263 (2024)
Abstract Aims Biomarkers are paramount for managing heart failure (HF) patients as prognostic and therapeutic efficacy index tools. Systemic levels of brain‐derived neurotrophic factor (BDNF) can add to the HF biomarker scenario, allowing for poten
Externí odkaz:
https://doaj.org/article/eb6cd4d156f04254a522c7ae29e3d288
Autor:
Ali Tavakoli Pirzaman, Mahdi Sepidarkish, Faezeh Alizadeh, Sarah Al-Obidy, Pouyan Ebrahimi, Nazanin Kianifard, Morteza Sheikhi Nooshabadi, Mehradad Jafari Tadi, Maryam Zolfaghari Dehkharghani, Safa Mousavi, Nassim Rezapour, Sara Mohammadnia, Andarz Fazlollahpour Naghibi, Kimia Bagheri, Mohammad-Hossein Asghari, Masomeh Bayani, David Rollinson, Robin B. Gasser, Ali Rostami
Publikováno v:
EClinicalMedicine, Vol 77, Iss , Pp 102855- (2024)
Summary: Background: Schistosoma mansoni infection poses a substantial public health challenge globally, and the World Health Organization (WHO) aims for the elimination of schistosomiasis by 2030. This study aimed to assess the current prevalence of
Externí odkaz:
https://doaj.org/article/4582ac82a82b40b0b2f4e92120a68045
Autor:
Maryam Zolfaghari Dehkharghani, Safa Mousavi, Nazanin Kianifard, Amin Fazlzadeh, Hamid Parsa, Ali Tavakoli Pirzaman, Andarz Fazlollahpour-Naghibi
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 55, Iss , Pp 101529- (2024)
Myocardial infarction (MI), a major global cause of mortality and morbidity, continues to pose a significant burden on public health. Despite advances in understanding its pathogenesis, there remains a need to elucidate the intricate molecular mechan
Externí odkaz:
https://doaj.org/article/a523052476a3452fa4ebfa3cd1c3a38a
Autor:
Tavakoli Pirzaman, Ali, Sepidarkish, Mahdi, Alizadeh, Faezeh, Al-Obidy, Sarah, Ebrahimi, Pouyan, Kianifard, Nazanin, Sheikhi Nooshabadi, Morteza, Jafari Tadi, Mehradad, Zolfaghari Dehkharghani, Maryam, Mousavi, Safa, Rezapour, Nassim, Mohammadnia, Sara, Fazlollahpour Naghibi, Andarz, Bagheri, Kimia, Asghari, Mohammad-Hossein, Bayani, Masomeh, Rollinson, David, Gasser, Robin B., Rostami, Ali
Publikováno v:
In eClinicalMedicine November 2024 77
Autor:
Zolfaghari Dehkharghani, Maryam, Mousavi, Safa, Kianifard, Nazanin, Fazlzadeh, Amin, Parsa, Hamid, Tavakoli Pirzaman, Ali, Fazlollahpour-Naghibi, Andarz
Publikováno v:
In IJC Heart & Vasculature December 2024 55
Inhibitory effect of microRNA-21 on pathways and mechanisms involved in cardiac fibrosis development
Autor:
Amirreza Khalaji, Saba Mehrtabar, Armin Jabraeilipour, Nadia Doustar, Hamed Rahmani Youshanlouei, Amir Tahavvori, Payam Fattahi, Seyed Mohammad Amin Alavi, Seyed Reza Taha, Andarz Fazlollahpour-Naghibi, Mahdieh Shariat Zadeh
Publikováno v:
Therapeutic Advances in Cardiovascular Disease, Vol 18 (2024)
Cardiac fibrosis is a pivotal cardiovascular disease (CVD) process and represents a notable health concern worldwide. While the complex mechanisms underlying CVD have been widely investigated, recent research has highlighted microRNA-21’s (miR-21)
Externí odkaz:
https://doaj.org/article/423ae8932d54471689d2cf1cd27c41c0
Autor:
Farzaneh Abbasi, Mustafa Almukhtar, Andarz Fazlollahpour-Naghibi, Faezeh Alizadeh, Kimia Behzad Moghadam, Mehrdad Jafari Tadi, Saleh Ghadimi, Kimia Bagheri, Hedye Babaei, Mohammad Hossein Bijani, Safoura Rouholamin, Maryam Razavi, Mahroo Rezaeinejad, Hiam Chemaitelly, Mahdi Sepidarkish, Maryam Farid-Mojtahedi, Ali Rostami
Publikováno v:
EClinicalMedicine, Vol 66, Iss , Pp 102327- (2023)
Summary: Background: Monitoring progress towards the WHO global target to eliminate hepatitis C virus (HCV) infection by 2030, entails reliable prevalence estimates for HCV infection in different populations. Little is known about the global burden o
Externí odkaz:
https://doaj.org/article/37ed377d7eb843888cfc0a2b555c2bf7
Autor:
Abbasi, Farzaneh, Almukhtar, Mustafa, Fazlollahpour-Naghibi, Andarz, Alizadeh, Faezeh, Behzad Moghadam, Kimia, Jafari Tadi, Mehrdad, Ghadimi, Saleh, Bagheri, Kimia, Babaei, Hedye, Bijani, Mohammad Hossein, Rouholamin, Safoura, Razavi, Maryam, Rezaeinejad, Mahroo, Chemaitelly, Hiam, Sepidarkish, Mahdi, Farid-Mojtahedi, Maryam, Rostami, Ali
Publikováno v:
In eClinicalMedicine December 2023 66
Autor:
Farid Mojtahedi, M., Sepidarkish, M., Almukhtar, M., Eslami, Y., Mohammadianamiri, F., Behzad Moghadam, K., Rouholamin, S., Razavi, M., Jafari Tadi, M., Fazlollahpour-Naghibi, A., Rostami, Z., Rostami, A., Rezaeinejad, M.
Publikováno v:
In Journal of Hospital Infection September 2023 139:82-92
Autor:
Javad Setareh, Ghazale Hoseinzade, Batoul Khoundabi, Mahsa Kamali, Ata Ebrahimi, Andarz Fazlollahpour-Naghibi, Mohammad Zareei, Mona Mohamaditabar, Ali Makaremi
Publikováno v:
BMC Ophthalmology, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Hemoglobin A1C (HbA1C) test is the best care evaluation measurement due to a strong correlation between the test results and diabetic complications. So, this cross-sectional study aimed to assess whether the level of HbA1C can pre
Externí odkaz:
https://doaj.org/article/2ed342d1defc40e28fe0e68c04c345e0